Validation Protocol Development
Writing what will be tested, on which data, against which acceptance criteria, approved before execution so results cannot be reinterpreted to fit an outcome.
AI model validation engineers independently verify that a model performs as specified for its stated intended use. They write validation protocols with predefined acceptance criteria, execute them separately from the development team, document results as controlled evidence, and define the conditions that trigger revalidation.
Validation differs from the evaluation a development team runs. Development evaluation improves the model; validation establishes, independently and against criteria fixed beforehand, whether it meets requirements. The distinction matters where evidence will be examined by a quality function, a governance committee, or a regulator. Taction Software staffs that separation deliberately, and our hire dedicated developers hub covers the modeling roles it verifies.

Our experts are ready to understand your business goals.






























































Validation output is a protocol, an executed result set, and a report that someone who was not present can assess. Acceptance criteria are fixed before execution, since criteria adjusted after seeing results are not criteria. The work below reflects that. Revalidation triggers appear among them because a model that changes, or whose population changes, has outrun the validation it passed.
Writing what will be tested, on which data, against which acceptance criteria, approved before execution so results cannot be reinterpreted to fit an outcome.
Establishing performance thresholds tied to intended use and clinical consequence, defined with clinical stakeholders rather than set at whatever the model achieves.
Building or securing validation data separate from anything used in development, since evaluation on data that influenced training establishes nothing.
Running the protocol as written, recording deviations, and documenting results as controlled evidence rather than as an analysis notebook nobody can reproduce.
Verifying performance across populations and at the edges of intended use, since aggregate results conceal where a model fails within its stated scope.
Specifying what changes require revalidation, including model updates, population shift, and source system changes that alter input characteristics.
Where software falls under a quality system, validation is a controlled activity with documentation requirements and independence expectations. Where it does not, the same discipline still produces evidence a governance committee can rely on. Engineers need to understand which regime applies without overstating their own role in determining it. The context spans our healthcare software work and shapes how evidence must be produced.
A developer validating their own model verifies their own assumptions. Separation between building and verifying is what makes the evidence worth anything.
Acceptance thresholds set after seeing results describe the model rather than testing it. Protocol approval precedes execution or the exercise is documentation.
A model validated for one population and setting is not validated elsewhere. The report states scope explicitly, since deployment beyond it requires new work.
Passing validation establishes performance at a point in time. Ongoing monitoring is a separate obligation, and validation defines what monitoring must watch.
Where a quality system applies, validation records are controlled documents with specific requirements. Where it does not, the same rigor still serves governance well.
Acceptance criteria encode clinical judgment about tolerable error. Engineers execute against criteria; they do not decide what performance is clinically sufficient.
This is verification discipline applied to statistical systems. The differentiating skills are protocol writing, independent data handling, and the willingness to report failure against criteria you did not set. The competencies below reflect that. Weight documentation rigor and independence above modeling technique, since the validator’s job is assessment rather than improvement.
Producing protocols specific enough to execute unambiguously, with deviations recorded rather than resolved silently during execution.
Determining sample sizes sufficient to test acceptance criteria meaningfully, and reporting where available data cannot support a conclusion.
Securing and controlling validation data with documented separation from development, since contamination invalidates the entire exercise.
Verifying performance across populations and at intended use boundaries, following practices comparable to our quality assurance approach in regulated software.
Producing records suitable for audit, with traceability from requirement to acceptance criterion to result, generated during execution rather than afterward.
Managing clinical data used for validation under appropriate controls, consistent with the practices described in our HIPAA engineering guidance.
The distinguishing question is whether they have failed a model. Validators who always pass either worked on excellent models or adjusted criteria. Our assessment centers on independence, protocol discipline, and willingness to report unwelcome results. Our delivery process includes review points where you can reassess fit.
We ask when a model did not meet criteria and what followed. Validators who never reported failure may have written criteria the model was certain to meet.
We ask how separated they were from development. Validators embedded in the modeling team verified assumptions they helped form.
We ask when acceptance criteria were approved. Criteria fixed after results are description rather than verification, regardless of how the document is titled.
We ask how they confirmed test data was untouched by development. Contaminated validation data produces results that mean nothing and look convincing.
We ask what happened when execution departed from protocol. Undocumented deviations undermine the record more than the deviation itself does.
We describe which validations each engineer executed and under what quality regime. We do not claim quality or regulatory credentials for engineers who lack them.
Validation engagements benefit from a vendor separate from whoever built the model, which is a reason to consider us where another party developed it, and a reason to separate teams where we built it ourselves. Structures below reflect that. Our engagement models accommodate either arrangement.
Validating a model built elsewhere, including vendor products, where independence is structural rather than something we must construct internally.
Where we built the model, validation is executed by engineers who did not develop it, with separation documented rather than asserted.
Writing protocols and acceptance criteria with your clinical stakeholders, which your own team then executes, suiting organizations with capacity but not methodology.
Where you own validation methodology, staff augmentation adds execution capacity working within your existing controlled processes.
A dedicated healthcare development team can include validation staffed independently of implementation, which produces cleaner evidence than combined roles.
Assessing purchased AI against your intended use, since vendor validation was performed on their population rather than yours.
Share who developed it, its intended use, and what validation data exists. Independence and data separation determine whether validation can mean anything.
Validation establishes performance against defined criteria within a stated scope. It does not establish clinical safety, regulatory conformity, or fitness beyond what was tested. Where intended use may create diagnostic or treatment claims, SaMD classification is assessed during discovery with your regulatory advisors. Taction holds no FDA clearance and does not certify models. Our security posture is described under our certifications and compliance information.
Validation reports state outcomes against criteria including failures, since a validation function that reports only success provides no assurance.
Every report defines the population, setting, and conditions tested. Deployment outside that scope requires new validation rather than assumed transfer.
Performance across populations appears in the report. Where a subgroup fails criteria, that is a finding rather than a footnote to an overall pass.
Meeting criteria means the model performed as specified on tested data. Clinical safety involves human review, monitoring, and organizational determination beyond validation.
Validation involving behavioral health populations requires additional handling. We built CHIPSS, a behavioral health system, where such constraints were foundational.
We would not set acceptance criteria after seeing results, validate a model using data that informed its development, or describe validation as certification of safety or compliance.
Cost concentrates in protocol development, independent data securing, and documentation rather than execution. Where validation data must be assembled and clinically reviewed, that dominates. We publish no figures on pass rates or performance, because those depend on the model and criteria. What we deliver is executed protocol and controlled evidence.
$40,000 to $80,000
Protocol development, acceptance criteria definition with clinical input, independent execution, subgroup verification, and documented report for one model.
$80,000 to $200,000
Validation across a model portfolio with standardized protocols, controlled documentation, revalidation trigger definition, and integration into quality processes.
Starting at $200,000
Multi-site validation with population variation, quality system integration, extended documentation, and validation across several clinical environments.
Discovery is paid and time-boxed. It produces a validation data availability assessment, independence analysis, criteria framework, and an itemized fixed-scope estimate.
Model count, validation data availability and clinical review needs, acceptance criteria complexity, subgroup scope, quality system documentation requirements, and independence arrangements.
Models change and populations shift. Budget for revalidation when triggers fire, protocol maintenance, and documentation updates as intended use or scope changes.
Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly.
Where regulated work such as formal validation under a quality system or a federal authorization pathway applies, that scope is priced separately from engineering.
Two questions matter. Whether the validator is genuinely independent, and whether they will report a failure. Taction Software has built healthcare software since 2013, more than twelve years, with over 200 healthcare projects delivered and ISO 27001 certification. Leadership brings more than twenty years of personal experience in the field, which is separate from company age.
We built Revive Ease and PainKare, both FDA-registered applications. That work established the verification discipline validation depends on.
We built Voyant Health, an EHR platform, and CHIPSS, a behavioral health system, which informs how validation scope should reflect real deployment conditions.
Taction Software holds ISO 27001 certification covering our information security management practices. It certifies our internal processes and does not certify any model.
Where we built the model, validation engineers are distinct from developers and that separation is recorded, since asserted independence is not evidence of it.
Validation that always passes provides no assurance. We report results as found, which occasionally means a model we built does not proceed.
Where structural independence matters more than familiarity, engaging a validator with no development relationship serves you better, and we say so.
We establish who built the model, its intended use, and what independent data exists, then present engineers with validation experience for your approval before placement.
One model runs $40,000 to $80,000, portfolio validation $80,000 to $200,000, and multi-site programs start at $200,000. Data acquisition and clinical review time are itemized separately.
Our delivery history includes the Voyant Health EHR platform, the CHIPSS behavioral health system, and the FDA-registered applications Revive Ease and PainKare, within more than 200 healthcare projects delivered since 2013.
Yes, with validation executed by engineers separate from the development team and that separation documented. Where structural independence matters more, we will recommend an unrelated validator.
No. It means the model met defined criteria on tested data within a stated scope. Clinical safety involves human review, monitoring, and organizational determination beyond validation.
Evaluation engineers build measurement used during development to improve models. Validation independently verifies performance against criteria fixed beforehand, producing evidence for quality and governance functions.
Share who built the model, its intended use and deployment scope, what independent validation data exists, your quality system requirements, and the engagement model you have in mind. We will assess whether meaningful independence is achievable and report results as found. We do not certify models or guarantee outcomes.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.